Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Bandim Health Project

Guinea-Bissau

Country: Guinea-Bissau

Ownership: Private

Established: 1978-01-01

Employees: -

Market Cap: -

Website: http://www.bandim.org

Clinical Trials

BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa

Phase 4

Conditions: Infant Morbidity
Infant Mortality
Non-Specific Effects of Vaccines
BCG

Interventions: Biological: BCG Vaccine

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-12

Lead Sponsor: Bandim Health Project

Target Recruit Count: 6000

Registration Number: NCT07005726

Locations: 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau

The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau

Phase 4

Conditions: Vaccine Reaction

Interventions: Other: Placebo
Biological: Oral polio vaccine

First Posted Date: 2024-02-20

Last Posted Date: 2024-02-20

Lead Sponsor: Bandim Health Project

Target Recruit Count: 80

Registration Number: NCT06266754

Locations: 🇬🇼
Bandim Health Project, Apartado 861, Bissau, Guinea-Bissau

Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau

Phase 4

Recruiting

Conditions: BCG Vaccination Reaction
Diabetes Mellitus

Interventions: Biological: BCG vaccine (two doses, 4 weeks apart)
Biological: Saline placebo (Two doses, 4 weeks apart)

First Posted Date: 2022-10-24

Last Posted Date: 2024-01-22

Lead Sponsor: Bandim Health Project

Target Recruit Count: 200

Registration Number: NCT05591339

Locations: 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau

Trial to Compare BCG-Bulgaria and BCG-Denmark

Phase 4

Recruiting

Conditions: Morbidity;Newborn
Morbidity;Infant
Non-specific Effects of Vaccines
Death; Neonatal
Death, Infant

Interventions: Biological: BCG-Denmark
Biological: BCG-Bulgaria

First Posted Date: 2022-05-31

Last Posted Date: 2024-01-22

Lead Sponsor: Bandim Health Project

Target Recruit Count: 15000

Registration Number: NCT05397678

Locations: 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau

Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria

Phase 4

Completed

Conditions: Effectiveness
Malaria

Interventions: Drug: Dihydroartemisinin-piperaquine 160 mg/20 mg Oral Tablet
Drug: Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet

First Posted Date: 2021-05-24

Last Posted Date: 2022-04-12

Lead Sponsor: Bandim Health Project

Target Recruit Count: 474

Registration Number: NCT04897919

Locations: 🇬🇼
Bandim Health Centre, Bissau, Bissau Codex, Guinea-Bissau

Measles and BCG Vaccines for Mother and Child

Phase 4

Recruiting

Conditions: Vaccine Preventable Disease
Measles
BCG Vaccination Reaction
Mother-Infant Interaction

Interventions: Other: Placebo
Biological: Measles vaccine
Biological: BCG vaccine

First Posted Date: 2021-05-24

Last Posted Date: 2024-01-19

Lead Sponsor: Bandim Health Project

Target Recruit Count: 2400

Registration Number: NCT04899765

Locations: 🇬🇼
Bandim Health Project, Bissau, Bissau Codex, Guinea-Bissau

Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?

Phase 4

Recruiting

Conditions: Infant Mortality
BCG

Interventions: Drug: BCG vaccination at first health facility contact

First Posted Date: 2020-12-08

Last Posted Date: 2024-01-22

Lead Sponsor: Bandim Health Project

Target Recruit Count: 22800

Registration Number: NCT04658680

Locations: 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

Phase 3

Completed

Conditions: Non-specific Effects of Vaccines
Immunosenescence
Heterologous Immunity
Morbidity
Covid19
Vaccine Preventable Disease

Interventions: Biological: Saline
Biological: BCG-Denmark

First Posted Date: 2020-09-09

Last Posted Date: 2024-08-22

Lead Sponsor: Bandim Health Project

Target Recruit Count: 1700

Registration Number: NCT04542330

Locations: 🇩🇰
Seniorhuset, Odense, Denmark

Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention

Not Applicable

Conditions: COVID-19
Respiratory Illness

Interventions: Other: Certified cloth face mask plus preventive information
Behavioral: Preventive information

First Posted Date: 2020-07-15

Last Posted Date: 2021-10-13

Lead Sponsor: Bandim Health Project

Target Recruit Count: 40000

Registration Number: NCT04471766

Locations: 🇬🇼
Bandim Health Project, Bissau, Bissau Codex, Guinea-Bissau

OPV as Potential Protection Against COVID-19

Phase 4

Conditions: Mortality
Morbidity
COVID
Poliovirus Vaccine, Oral
Non-Specific Effects of Vaccines

Interventions: Biological: oral polio vaccine + information
Behavioral: Information

First Posted Date: 2020-06-24

Last Posted Date: 2022-03-18

Lead Sponsor: Bandim Health Project

Target Recruit Count: 3400

Registration Number: NCT04445428

Locations: 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy